FDA responds to BPA Subcommittee report

Source of Article:  http://members.ift.org/IFT/Pubs/Newsletters/weekly/nl_102908.htm

In light of the critical findings of the Bisphenol A (BPA) Subcommittee Report, the U.S. Food and Drug Administration said it will revisit its recent BPA safety assessment, which the subcommittee said was inadequate.

 

 

“The FDA agrees that, due to the uncertainties raised in some studies relating to the potential effects of low-dose exposure to bisphenol A, additional research would be valuable,” reads the agency’s statement. “The FDA is already moving forward with planned research to address the potential low-dose effects of bisphenol A, and we will carefully evaluate the findings of these studies.”

The FDA’s Science Board will review the subcommittee’s report on October 31. The subcommittee reviewed an FDA draft safety assessment issued in August that said the chemical BPA is safe at current levels found in plastic baby bottles and canned foods. Some scientists and lawmakers felt the FDA report relied too heavily on industry-funded research and ignored other studies suggesting BPA is harmful.

In response to the criticism, the FDA asked a panel of scientific experts to form a subcommittee to review the August report. The subcommittee’s report disagreed with the FDA’s decision to dismiss many of the negative BPA studies. “The Subcommittee finds that the draft assessment conclusions are not supported by the available data and science,” stated the panel’s report.

In response to the panel’s critical findings, the FDA is reviewing the August report. The FDA stated that in the meantime, consumers should know that
“based on all available evidence, the present consensus among regulatory agencies in the United States, Canada, Europe and Japan is that current levels of exposure to BPA through food packaging do not pose an immediate health risk to the general population, including infants and babies.”
Regarding Canada, the FDA noted that Health Canada’s recent assessment of the dangers bisphenol A poses for newborns and infants up to 18 months of age concludes that exposure levels are below the levels that could cause health effects. The FDA does concede, though, that “out of an abundance of caution, the Government of Canada is taking steps to restrict the use of BPA.”

FDA News Release

BPA Subcommittee Report

Briefing Information for Science Board Meeting

Wall Street Journal article

 

 

Main Page

setstats            Copyright (C) All rights reserved under FoodHACCP.com

            If you have any comments, please send your email to info@foodhaccp.com